Study On Bio Pharmaceutical Industry Technology Innovation Path Of Jilin Province

In recent years, bio pharmaceutical industry increases, the rapid development ofmodern biotechnology to genetic engineering, cell engineering, enzyme engineering,fermentation engineering as the representative, to create a huge benefits. The currentglobal pharmaceutical market profits by each five years to quadruple the rate ofgrowth, behind the bio pharmaceutical industry rapid development, not only toincrease profitability, enhance the comprehensive competitive strength of the countrymore, enhance the level of national health, along with the gradual improvement ofeconomic level, people become more for health care, healthy living demand is high,many were classified as incurable diseases such as heart disease, hypertension,diabetes mellitus, infectious disease, can be broken by biological technology, itopened a huge space medicine market. Heavy huge profits bombs and biologicalmedicine created, for the promotion of regional and national economy, the adjustmentof economic structure, has great effect on the international market, in order to seizethe bio pharmaceutical market is high, many countries have the biological medicineindustry development for national key cultivation object, America with biomedicaltechnology the world’s most advanced, most of the bio pharmaceutical patents andlargest bio medicine industry base, Europe has the world’s largest biologicalMedicines Co, Japan put forward the "biotechnology industry country" slogan, thesecountries are divided up nearly90%of the world pharmaceutical industry marketshare, to obtain huge profits at the same time, also mastered the initiative market inother countries, in the trade surplus, China is also the bio pharmaceutical industry asthe focus on fostering strategic emerging industries, will promote the development ofthe industry, to achieve industrial upgrading and transformation, promoted thenational technical strength, enhance international competitiveness as the strategicfocus of the current.Technological innovation capability is the core element of bio pharmaceuticalindustry, no advanced biological technology support, bio pharmaceutical industrymust be attached to the same industry in other countries under torsion, difficult toachieve status, in order to develop bio pharmaceutical industry, strengthen the countryin the face of the international competition is competition, must strengthen the biopharmaceutical industry technological innovation strength, with continuoustechnological innovation to drive the core competence of technology industry, andthen realize the leap industrial grade. As the most populous country in the world,America predicted that within ten years Chinese will be market globalbiopharmaceutical products biggest, which fully demonstrates the great potential inthe pharmaceutical market in our country, our country existing biological MedicinesCo more than700, in2013the year of biological medicine industry total industrial output value reached2Yuan, since the863plan, our country in human functionalgene research project, in order to obtain nearly100has independent intellectualproperty rights of the functional genes, in the world has more than40kinds of bioengineering drugs research and development success, producing18to China, China10the world’s best-selling drug can produce8, at present, China has nearly30biotechnology drugs into clinical application, nearly180into the clinical researchstage. But as the bio pharmaceutical industry in developing countries, China in thebiological technology, biological technology research and innovation is also evidentin the backward position.Jilin province is the core of development of Chinese bio pharmaceutical industryregional development growth area in Northeast China, is one of the biotechnologyindustrialization base for national key construction and National Biotechnology fourgathering areas, bio pharmaceutical industry in the country ranked second, based onnatural advantages, in terms of biomedical output accounts for about13%of thenational total, genetic engineering drugs and vaccines is one of Asia’s largestproduction base, is also China’s first genetic engineering interferon pilot productionbase and the first genetic engineering vaccine (CHO vaccine) pilot production base,whether in basic skills, platform construction, product categories, policy support andthe level of research and development are in the national advanced level. But facingthe biological technology change rapidly, in the face of strong competition fromforeign countries, bio pharmaceutical industry in Jilin province is also facing the hugechallenge, embodied in the technology innovation level is low, lack of capacity ofindependent innovation, R&D Co., low investment, human resources reserves,intellectual support, incomplete industry Chain Development Co. industrialcomprehensive strength, lower, less professional intellectual property, protection isnot enough and so on, in order to enhance the overall strength of the biopharmaceutical industry in Jilin Province, the adjustment of economic structure inJilin Province, enhance the comprehensive competitiveness of Jilin Province, theintegration of the technological innovation path of biological medicine industry inJilin Province, choose suitable for bio pharmaceutical industry technology innovationmodel of development, become the a pressing matter of the moment.The industrial cluster innovation is an effective mode to enhance the biologicalmedicine industry in Jilin province technology innovation strength, therefore must bebased on learning from developed countries, Europe, Japan and other America or areabio pharmaceutical industry development on the road, the industrial cluster as thebreakthrough point, relying on technological innovation mode of exploration in thebio pharmaceutical industry cluster, expand the scale of industrial clusters, shorten theoperation cycle industry, building collaborative innovation system research, toupgrade the industry overall strength. This text is divided into six parts, the maincontents and conclusions are as follows. This text is divided into six parts, the maincontents and conclusions are as follows.The first part, the introduction, is the bird’s eye view, summarized the whole text,the research background, the research goal and the research significance for theoverall summary and discussion, and the domestic and foreign research present situation about the development of bio pharmaceutical industry and technologyinnovation path problem are generally analysis, at the same time to show the overalltechnology roadmap method and process of the full text.The second part, theoretical overview, a detailed introduction of the innovationtheory, industrial cluster theory and the theory of industrial chain. In the innovationtheory, according to the time and genre, the Inpet innovation theory, technologyinnovation theory in detail, at the same time on the technology innovation theorymodel is also analyzed, in the theory of industrial cluster in the concept of industrialcluster and the related theory of the development process of carding; in the industrialchain theory in the paper, starting from the relevant concepts of the industrial chain,and the industrial chain constitution system is analyzed and introduced, including theformation and characteristics of the industrial chain, to industry association theory,supply chain theory, value chain theory and the industry cluster theory. It lays thetheoretical foundation of a full text.The third part, an overview of the development of pharmaceutical industry inChina and foreign countries at first part, starting from the bio pharmaceutical industryrelated concepts, the concept of bio pharmaceutical industry, pharmaceutical industry,biological technology and so on were distinguished and introduces American, Europe,Japan, from three countries or regions of the bio pharmaceutical industry developmentstatus quo, the development situation of the global bio pharmaceutical industry tosummarize, and taking this as the background, the status of domestic biopharmaceutical market analysis, mainly from the two aspects of investment situationand national policy development space analysis of biological medicine industry in ourcountry and the environment, and through the whole of Bohai rim region, YangtzeRiver Delta and the Pearl River Delta region three area of bio pharmaceutical industryto describe the China’s bio medical industry regional distribution is summarized,become the main content of this paper.The fourth part, Jilin Province biological pharmaceutical analysis of thedevelopment status and SWOT industry part, firstly, the overall state of the biologicalmedicine industry in Jilin province from the basic ability, platform construction,government policy, the level of research and development, Chinese medicine drugability and so on are analyzed briefly, secondly resources status of bio pharmaceuticalindustry in Jilin province from four aspects natural resources, ecological resources,northern medicine resources,and infrastructure conditions are summarized, based onthe following analysis development status and industry resources above, focuses onthe development of biological medicine industry in Jilin province were analyzed bySWOT, and on the basis of summarizing the bottleneck factors restricting thedevelopment of biological medicine industry in Jilin Province, to lay the foundationfor the exploration of after the paper path.The fifth part, part of the bio pharmaceutical industry in Jilin province the pathof technological innovation research, first carries on the analysis of techniqueinnovation on bio pharmaceutical industry from the perspective of industrial cluster,dynamic mechanism of bio pharmaceutical industry cluster technology innovation areanalyzed and validated, from the CO competition mechanism, industrial clusters of study three aspects of mechanism and spillover and diffusion mechanism the biopharmaceutical industry cluster mode to promote the industrial technologicalinnovation capability promotion effect are analyzed, and then separately from thetechnical innovation decision-making, technical innovation achievements operationand achievements of technological innovation diffusion three process is described,based on the industry cluster theory and technological innovation theory as the guide,for the selection and the research to the Jilin province of biological medicineindustrial technology innovation path, respectively, proposed the building ofinnovation system of industry university research collaboration and the cultivation ofbio pharmaceutical industry development, clear focus and direction, imitationinnovation and construction of open innovation pattern of the four major paths, laythe foundation for the next part of advice, direction.The sixth part, the policy suggestion part, according to the above obtainedindifferent technological innovation path, combined with the bio pharmaceuticalindustry in Jilin province development present situation and the question, from thetechnical innovation ability, the role of leading enterprises, improve the industrialchain, pay attention to personnel training, to develop the international market, putforward to promote the bio pharmaceutical industry in Jilin province the level oftechnological innovation policy recommendations focus on the role of government inseveral aspects.